Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification.

Isothermal amplification using a chemical heating device for point-of-care detection of HIV-1. PLoS One (2012) 1.43

Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol (2013) 1.27

Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. J Virol Methods (2010) 1.01

Electricity-free amplification and detection for molecular point-of-care diagnosis of HIV-1. PLoS One (2014) 0.96

Development and evaluation of a reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71. J Clin Microbiol (2010) 0.95

Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method. J Clin Microbiol (2010) 0.95

Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron (2015) 0.91

Detection of Acute HIV-1 Infection by RT-LAMP. PLoS One (2015) 0.88

Development and Evaluation of Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) Assay Coupled with a Portable Device for Rapid Diagnosis of Ebola Virus Disease in Guinea. PLoS Negl Trop Dis (2016) 0.83

Rapid and sensitive identification of the herbal tea ingredient Taraxacum formosanum using loop-mediated isothermal amplification. Int J Mol Sci (2015) 0.81

Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification. Microbiol Immunol (2011) 0.78

Viral Hemorrhagic Fever Diagnostics. Clin Infect Dis (2015) 0.78

Survey and Visual Detection of Zaire ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra Leone. Front Microbiol (2015) 0.78

Pre-symptomatic diagnosis and treatment of filovirus diseases. Front Microbiol (2015) 0.77

Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood. J Infect Dis (2016) 0.75

Loop-Mediated Isothermal Amplification (LAMP) for Rapid Detection and Quantification of Dehalococcoides Biomarker Genes in Commercial Reductive Dechlorinating Cultures KB-1 and SDC-9. Appl Environ Microbiol (2016) 0.75

Enhancement of Polymerase Activity of the Large Fragment in DNA Polymerase I from Geobacillus stearothermophilus by Site-Directed Mutagenesis at the Active Site. Biomed Res Int (2016) 0.75

Rapid detection of contagious ecthyma by loop-mediated isothermal amplification and epidemiology in Jilin Province China. J Vet Med Sci (2015) 0.75

Visual Detection of West Nile Virus Using Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Vertical Flow Visualization Strip. Front Microbiol (2016) 0.75

Rapid detection of feline morbillivirus by a reverse transcription loop-mediated isothermal amplification. J Vet Med Sci (2015) 0.75

Strategies in Ebola virus disease (EVD) diagnostics at the point of care. Crit Rev Microbiol (2017) 0.75

Lyophilized visually readable loop-mediated isothermal reverse transcriptase nucleic acid amplification test for detection Ebola Zaire RNA. J Virol Methods (2017) 0.75

The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17

Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34

Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40

Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62

Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77

Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11

PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96

Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28

Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26

Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52

Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49

Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20

Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18

Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77

Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71

Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69

Gain-of-function experiments on H7N9. Science (2013) 3.67

Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62

Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51

The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50

Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47

Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45

Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15

Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99

The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89

A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80

Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77

Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72

Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71

Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70

Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67

Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62

Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58

Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol (2008) 2.58

Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57

Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55

Pneumonia from human coronavirus in a macaque model. N Engl J Med (2013) 2.47

Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45

Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44

Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44

Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. J Virol (2009) 2.41

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33

Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33

Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A (2013) 2.29

High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog (2009) 2.29

Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24

Pause on avian flu transmission research. Science (2012) 2.24

Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24

Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23

Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19

Polymorphisms and the differential antiviral activity of the chicken Mx gene. Genome Res (2002) 2.18

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog (2008) 2.10